Synergistic effect of α‐glucosidase inhibitors and dipeptidyl peptidase 4 inhibitor treatment

Monotherapy of α‐glucosidase inhibitor (α‐GI) or dipeptidyl peptidase 4 (DPP4) inhibitor does not sufficiently minimize glucose fluctuations in the diabetic state. In the present study, we evaluated the combined effects of various of α‐GI inhibitors (acarbose, voglibose or miglitol) and sitagliptin,...

Descripción completa

Detalles Bibliográficos
Autores principales: Horikawa, Yukio, Enya, Mayumi, Iizuka, Katsumi, Chen, Gui Ying, Kawachi, Shin‐ichi, Suwa, Tetsuya, Takeda, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2010
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014919/
https://www.ncbi.nlm.nih.gov/pubmed/24843484
http://dx.doi.org/10.1111/j.2040-1124.2010.00081.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014919/
https://www.ncbi.nlm.nih.gov/pubmed/24843484
http://dx.doi.org/10.1111/j.2040-1124.2010.00081.x

Ejemplares similares